ACHE and Alzheimer disease: More importantly, in the field of AD research, myricetin has shown multifaceted therapeutic potential: it not only alleviates Fe2+‐induced SH‐SY5Y cell death but also inhibits acetylcholinesterase (AChE), reduces brain iron content, reverses scopolamine‐induced cognitive dysfunction, and mitigates oxidative stress damage in AD mouse models [30].